HAIC Combined With Lenvatinib and PD-1 Inhibitor in Infiltrative Hepatocellular Carcinoma

Clinical trial NCT06333561 · RECRUITING

Trial details

NCT number: NCT06333561
Sponsor: Sun Yat-sen University
Status: RECRUITING
Study type: OBSERVATIONAL

Hepatocellular Carcinoma Lenvatinib PD-1 Inhibitor Hepatic Arterial Infusion Chemotherapy

Start date: 2021-01-01
Primary completion: 2024-12-30
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.